FMR CORP 13D and 13G filings for ADC Therapeutics SA:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-10 09:37 am Sale |
2023-04-06 | 13G | ADC Therapeutics SA ADCT |
FMR CORP | 40,444 0.050% |
-4,613,009 (-99.13%) |
Filing |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | ADC Therapeutics SA ADCT |
FMR CORP | 4,653,453 6.050% |
-3,019,220 (-39.35%) |
Filing |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | ADC Therapeutics SA ADCT |
FMR CORP | 7,672,673 9.999% |
-88,912 (-1.15%) |
Filing |
| 2021-04-12 1:05 pm Unchanged |
2021-04-09 | 13G | ADC Therapeutics SA ADCT |
FMR CORP | 7,761,585 10.116% |
0 (Unchanged) |
Filing |
| 2021-02-08 10:15 am Sale |
2021-02-05 | 13G | ADC Therapeutics SA ADCT |
FMR CORP | 7,761,585 9.999% |
-148 (-0.00%) |
Filing |
| 2020-12-10 09:15 am Purchase |
2020-12-09 | 13G | ADC Therapeutics SA ADCT |
FMR CORP | 7,761,733 10.000% |
7,761,733 (New Position) |
Filing |